Superbugs: first independent comparison of pharma companies' efforts to address drug-resistant infections

Amsterdam, the Netherlands, 23 January, 2018 – The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, finds that as well as developing new drugs companies are also dismantling the incentives that encourage sales staff to oversell antibiotics, setting limits on the concentration of antibiotics in factory wastewater released into the environment, and tracking the spread of superbugs.

Get in touch

Back to top |